NovaBridge Biosciences American Depositary Shares
NBP
69 hedge funds and large institutions have $104M invested in NovaBridge Biosciences American Depositary Shares in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 21 increasing their positions, 20 reducing their positions, and 15 closing their positions.
688% more call options, than puts
Call options by funds: $134K | Put options by funds: $17K
5% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 20
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3.1% less ownership
Funds ownership: 16.18% → 13.08% (-3.1%)
8% less funds holding
Funds holding: 75 → 69 (-6)
16% less capital invested
Capital invested by funds: $123M → $104M (-$19.6M)
40% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$2.92M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.64M |
| 3 |
Millennium Management
New York
|
+$1.28M |
| 4 |
Barclays
London,
United Kingdom
|
+$1.25M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$719K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nomura Holdings
Tokyo,
Japan
|
-$8.22M |
| 2 |
AC
Armistice Capital
New York
|
-$7.09M |
| 3 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$3.72M |
| 4 |
Goldman Sachs
New York
|
-$2.29M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$1.84M |
NBP Hedge Fund Activity: Q4 2022 in Review
69 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q4 2022, worth a combined $104M — down 16% from $123M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of NBP and 9 opened new positions — a net loss of 6 holders — while 20 trimmed existing stakes and 21 added.
The largest buyer was JP Morgan Chase, adding an estimated $2.92M. The largest seller was Nomura Holdings, cutting an estimated $8.22M.
- 69 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q4 2022, down from 75 in Q3 2022.
- Funds reported $104M of NovaBridge Biosciences American Depositary Shares stock for Q4 2022, down 16% quarter-over-quarter.
- 9 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q4 2022 and 15 closed out, a net change of -6 holders.
- The largest NovaBridge Biosciences American Depositary Shares buyer in Q4 2022 was JP Morgan Chase, an estimated $2.92M added.
- The largest NovaBridge Biosciences American Depositary Shares seller in Q4 2022 was Nomura Holdings, an estimated $8.22M sold.
Based on aggregated 13F filings for Q4 2022.